Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?

Annals of the Rheumatic Diseases

Volumn 69, Issue 12, 2010, Pages 2160-2164

  Eder, Lihi ^a   Chandran, Vinod ^a   Shen, Hua ^b   Cook, Richard J ^b   Gladman, Dafna D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; DISEASE ACTIVITY; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; STATISTICS;

ADULT; AGED; ARTHRITIS, PSORIATIC; BACK PAIN; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; SACROILIITIS; SEVERITY OF ILLNESS INDEX;

EID: 78649749326     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.129726     Document Type: Article

References (14)

1. Chandran V, Barrett J, Schentag CT, et al. Axial psoriatic arthritis: update on a long-term prospective study. J Rheumatol 2009;36:2744-50.
2. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
3. Taylor WJ, Harrison AA. Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Arthritis Rheum 2004;51:311-15.
4. Fernández-Sueiro JL, Willisch A, Pértega-Díaz S, et al. Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis. Arthritis Rheum 2009;61:386-92.
5. Lukas C, Landewé R, Sieper J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18-24.
6. van der Heijde D, Lie E, Kvien TK, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:1811-18.
7. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
8. Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 2006;54:569-78.
9. Kennedy LG, Jenkinson TR, Mallorie PA, et al. Ankylosing spondylitis: the correlation between a new metrology score and radiology. Br J Rheumatol 1995;34:767-70.
10. Pepe MS. An interpretation for the ROC curve and inference using GLM procedures. Biometrics 2000;56:352-9.
11. Chandran V, Tolusso DC, Cook RJ, et al. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. J Rheumatol 2010;37:809-15.
12. Pedersen SJ, Sørensen IJ, Hermann KG, et al. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 2010;69:1065-71.
13. O'Shea FD, Chandran V, Toloza SMA, et al. Does axial disease exhibit a different phenotype in primary ankylosing spondylitis versus psoriatic arthritis? Arthritis Rheum 2006;54:4091.
14. Mease PJ, Antoni CE, Gladman DD, et al. Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 2005;64:ii49-54.